Texas Oncology, P.A. - Tyler

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Gastric and oesophageal cancer1 trial
• Lung cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 34 trials

Status

• Recruiting3 trials
• Not yet recruiting1 trial

Lead sponsor

• Daiichi Sankyo2 trials
• BioNTech SE1 trial
• EMD Serono Research & Development Institute, Inc.1 trial

Running trials

• Recruiting

  A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

  NCT07549412· Phase 3· EMD Serono Research & Development Institute, Inc.· Source

  Contact: Communication Center

• Recruiting

  A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

  NCT07365995· Phase 3· BioNTech SE· Source

• Recruiting

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· Phase 3· Daiichi Sankyo· Source

• Recruiting

  A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

  NCT06203210· Phase 3· Daiichi Sankyo· Source

  Contact: Principal Investigator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Lung cancer1 recruiting
• Prostate cancer1 recruiting